Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma

  • Ngozi E. Dufty*
  • , Gerry Gilleran
  • , Daniel Hawkins
  • , Laura J. Else
  • , Stephen Taylor
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Article numberdks486
Pages (from-to)972-974
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume68
Issue number4
DOIs
Publication statusPublished - Apr 2013
Externally publishedYes

Bibliographical note

Funding Information:
S. T. has received educational and/or travel grants from Pfizer, VIIV and Janssen Pharmaceuticals. All other authors: none to declare.

Funding Information:
The research leading to these results received funding from the European Community’s Seventh Framework Program (FP7/2007-2013) under the project ‘Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)’—grant agreement no. 223131 and the Agence Natio-nale de Recherche sur le SIDA et les Hépatites virales (ANRS, France).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HBV
  • HIV antiviral pharmacology
  • Hepatic transplantation
  • Immunosuppression

Cite this